Skip to main content
Article thumbnail
Location of Repository

A Functional Screen for Regulators of CKDN2A Reveals MEOX2 as a Transcriptional Activator of INK4a

By Jeffrey T. Irelan, Ana Gutierrez del Arroyo, Abel Gutierrez, Gordon Peters, Kim C. Quon, Loren Miraglia and Sumit K. Chanda


The CDKN2A locus encodes two important tumor suppressors, INK4a and ARF, which respond to oncogenic stresses by inducing cellular senescence. We conducted a genome-scale cDNA overexpression screen using a reporter containing INK4a regulatory sequences to identify novel transcriptional activators of this locus. This screen revealed 285 cDNAs that putatively regulate the transcriptional activation of INK4a. Of these, 56 are annotated as transcription factors, including two previously reported activators of the locus, ETS2 and JUNB. Fourteen genes were further validated for activity and specificity, including several homeodomain proteins. We found that the transcription of one of these, the homeodomain protein MEOX2 (GAX) is enhanced in primary cells during the induction of senescence, and forced expression of this protein results in the induction of premature senescence. We further demonstrate that MEOX2-induced senescence is dependent upon INK4a activity, and chromatin immunoprecipitation studies indicate that MEOX2 directly binds the INK4a promoter. These results support a role for this homeodomain protein as a direct regulator of INK4a transcription and senescence in human cells

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2002). Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines.
    2. (2005). Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways.
    3. (2005). BRAFE600-associated senescence-like cell cycle arrest of human naevi.[see comment].
    4. (2001). Characterization of regulatory elements on the promoter region of p16(INK4a) that contribute to overexpression of p16 in senescent fibroblasts.
    5. (2005). Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.[see comment].
    6. (2007). d’Adda di Fagagna F
    7. (2002). HOX and non-HOX homeobox genes in leukemic hematopoiesis.
    8. (2005). Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice.
    9. (2002). INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence.
    10. (1993). Molecular cloning of a diverged homeobox gene that is rapidly down-regulated during the G0/G1 transition in vascular smooth muscle cells.
    11. (2005). Oncogene-induced senescence as an initial barrier in lymphoma development.[-see comment].
    12. (2001). Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence.
    13. (1997). p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene.
    14. (2001). Parsing Ink4a/Arf: ‘‘pure’’ p16-null mice.
    15. (2005). Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors.
    16. (2007). The homeobox gene GAX activates p21WAF1/CIP1 expression in vascular endothelial cells through direct interaction with upstream AT-rich sequences.
    17. (2001). The INK4a/ARF network in tumour suppression.
    18. (1998). The p16INK4a/CDKN2A tumor suppressor and its relatives.
    19. (2005). Tumour biology: senescence in premalignant tumours.[see comment].

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.